Talkspace May Be A Compelling Buy Despite Recent Setback

Photo of author
Written By Dean McHugh

Shares of Talkspace saw a significant rally earlier this year, nearly doubling by April, only to retreat by almost 30% from their peak near $4. Despite this pullback, key performance metrics indicate robust growth, presenting a promising entry point for investors.

Company Background

Credits: DepositPhotos

Talkspace offers a therapy app that provides mental health services, making therapy more accessible through an easy-to-use interface. The company has steadily expanded its user base and partnerships with mental health providers across the U.S.

In 2023, Talkspace introduced Medicare coverage in 11 states, potentially reaching an additional 10 million covered lives. Furthermore, the company launched a health collective marketplace on its app, allowing users to purchase services from third parties like Evernow (menopause treatment) and Aura (sleep wellness).

Growth Drivers

  1. Medicare Expansion: Talkspace’s inclusion in Medicare in key states like California and New York opens up a substantial market. Medicare covers 65 million lives, with the initial rollout adding 10 million lives to Talkspace’s addressable market.
  2. Health Collective Marketplace: The new feature on the app enables users to access and purchase services from third parties, enhancing the app’s utility and user engagement.
  3. Enterprise Focus: Talkspace is shifting its marketing efforts towards large insurance plans and employers, aiming for more efficient user acquisition. This strategic pivot is expected to drive sustained growth.
  4. Psychiatry Services Expansion: Talkspace views psychiatry as a significant growth opportunity. Currently focused on therapy and self-help, expanding into psychiatry will diversify its revenue streams.

Q1 Performance

Talkspace demonstrated impressive growth in Q1, highlighting the vast potential of its addressable market. Key takeaways from the earnings report include:

  • Revenue Growth: Revenue grew by 36% year-over-year (y/y) to $45.4 million, surpassing Wall Street’s expectations. Revenue from payor sessions grew by 92% y/y, reflecting a strategic shift towards partnerships with health providers.
  • Provider Network Expansion: The provider network expanded to over 5,500 providers, up 47% y/y and 6% sequentially from Q4.
  • Direct to Enterprise: Despite some macro headwinds, direct-to-enterprise revenue grew by 14% y/y, contributing $9.9 million to total revenue.
  • Profitability: Operating expenses have sequentially declined each quarter over the past year, leading to the company’s first-ever adjusted EBITDA profit in Q1. Talkspace projects $4-$8 million in adjusted EBITDA profits for the year, a notable improvement from a $14 million loss last year.


At a current share price of around $2.50, Talkspace’s market cap stands at $403.7 million. With $120.3 million in cash on the balance sheet, the enterprise value is approximately $283.4 million.

Talkspace is guiding to $185-$190 million in revenue for the current year, representing 23-30% y/y growth. For FY25, consensus estimates project $223.7 million in revenue, or 18% y/y growth. This results in modest valuation multiples:

  • 1.5x EV/FY24 revenue
  • 1.3x EV/FY25 revenue

Talkspace Fundamentals Remain Strong

Credits: DepositPhotos

Despite the recent pullback in share price, Talkspace’s fundamentals remain strong, driven by significant growth opportunities and operational efficiencies. The company’s Medicare expansion and new health collective marketplace feature are expected to drive further growth.

Additionally, the enterprise focus and potential expansion into psychiatry services add to the bullish outlook.

With the current dip offering an attractive entry point, Talkspace appears undervalued, providing a compelling opportunity for investors.

The company is well-positioned to capitalize on the growing demand for mental health services, supported by its robust platform and strategic initiatives.


You should read and understand this disclaimer in its entirety before joining or viewing the website or email/blog list of (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help.

The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at; the Financial Industry Regulatory Authority (the "FINRA") at, and relevant State Securities Administrator website and the OTC Markets website at The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.

The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.

By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link: and

By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.